EU committee recommends omega-3 supplements during pregnancy

Pregnant women should take a daily supplement of omega-3 acids, an EU supported consensus committee has recommended. The supplement would increase the likelihood of a healthy birth and boost child development. The committee, composed of more than 50 nutritional experts from the EU-funded projects Perinatal Lipid Nutrition Group (PeriLip) and Early Nutrition Programming (EARNEST), said it had found that women who included DHA in their diet had healthier pregnancies, that their children had healthier birth weights and that they were less likely to give birth prematurely.

According to the recommendation, also supported by seven international scientific organisations, pregnant and nursing mothers should take 200 mailgrams per day of a form of omega-3 fatty acids called docosahexaenoic acid (DHA), which can be found in fatty fish such as salmon and mackerel. DHA intake has been linked to brain and eye development.

"Based on the systematic reviews of the available evidence, this EU-supported group of international experts unanimously concluded that women should have a regular supply of the omega-3 fatty acid DHA during pregnancy and the breastfeeding period, as it is of great importance for the child's health," told Professor Berthold Koletzko, from the Children's Hospital at the University of Munich, Germany.

The committee found however that the diets of western mothers tended to be low in foods that would provide the necessary dose. The experts believe that this could be explained by limited levels of awareness of the role of omegas in infant development.

DHA supplements have been linked with impacts on various ailments and conditions. Recent evidence has suggested that they can ease the symptoms of disorders such as schizophrenia, depression, dyslexia and Alzheimer's.

The Food Standards Agency currently advises that the consumption of two portions of fatty sea fish per week, necessary to gain the recommended levels of DHA, is generally safe for pregnant and breast-feeding women.

It also advises that DHA can also be found in other forms, including in supplements.

For further information, please visit:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

COVID-19 vaccine protection wanes after three mont…

The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses, a study says. The findings - drawn from datasets...

New study adds more evidence for Omicron immune ev…

A new study from Columbia researchers, in collaboration with scientists at the University of Hong Kong, adds more evidence that the omicron variant can evade the immune p...

European Commission grants conditional marketing a…

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announce...

Stopping dementia at the nose with combination of …

Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A research group from the Department of Tran...

Vaxzevria significantly boosted antibody levels ag…

AstraZeneca's Vaxzevria (ChAdOx1-S [Recombinant]) significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose boo...

Treatments in weeks, not months: Scientists develo…

An international team of scientists has created a plan for an accelerated pipeline for developing drug cocktails to battle the COVID-19 pandemic. The pipeline could speed...

Scientists identify antibodies that can neutralize…

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike pro...

COVID-19 can trigger self-attacking antibodies

Infection with the virus that causes COVID-19 can trigger an immune response that lasts well beyond the initial infection and recovery - even among people who had mild sy...

Leiden University Medical Center and Intravacc to …

Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, today announced a partnership with ...

Pfizer and BioNTech sign new global collaboration …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based v...

AstraZeneca and Ionis close agreement to develop a…

AstraZeneca has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as IONIS-TTR-LRX. ...

COVID-19 - Omicron: resistant to most monoclonal a…

The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant...